Home > Boards > US OTC > Medical - Equipment > GeneSYS ID Inc. (GNID)

GNID CSO and General Counsel MARK BASILE forgot

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
MDRESEARCH Member Profile
 
Followed By 53
Posts 11,598
Boards Moderated 0
Alias Born 11/26/14
160x600 placeholder
MDRESEARCH   Tuesday, 03/27/18 02:50:47 PM
Re: None
Post # of 32391 
GNID CSO and General Counsel MARK BASILE forgot to mention in this Article, it was HIS COMPANY, HIS LEADERSHIP, and He's the one who CUT the Deal.
He Appears finished in Public Companies. What a JOKE.

Mark Basile GNID Spewing "MINUTIA" in Third Person.

"I have seen OTC company’s trade at $7.00, then fall to .005 in a matter of 6 months, due directly to the unabashed selling of stock a lender receives at a discount – and they don’t give a rat’s ass about the CEO, the company or its shareholders. They are not “investors”. They are lenders and have figured out a very clever, and sometimes, legal way to extract an enormous return on monies loaned to the company, no matter what they call the transaction."

The Problem: FAILURE by a CEO in PENNYLAND, is not only an Acceptable Practice, it REWARDS a CEO... It's much EASIER for CEO to make money selling Company shares, than Build a Company.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist